We sought to determine whether online use of a beat-by-beat cardiovascular index, CARDEANா (Alpha-2, Lyon, France), modifies the incidence of patient movement during colonoscopy under anesthesia. METHODS: Monitoring included an electrocardiogram, oscillometric and noninvasive beat-bybeat arterial blood pressure, O 2 saturation, bispectral index (BIS), and CARDEAN. CARDEAN consists of beat-by-beat Finapresா (Ohmeda, Madison, WI) combined with an algorithm that detects hypertension followed by tachycardia and produces an index scaled 0 to 100. The anesthesiologist was denied access to Finapres and CARDEAN. Propofol was adjusted to keep 40ϽBISϽ60. Alfentanil 3.5 g ⅐ kg Ϫ1 was administered according to conventional signs (tachycardia, hypertension, and movement), unless the patient had signs of brady/apnea or SpO 2 Ͻ95%. One hundred fifty-nine patients presenting for colonoscopy under propofol anesthesia were prospectively randomized to (i) control: no other intervention, or (ii) CARDEAN: in addition to conventional signs, an observer instructed the anesthesiologist to administer alfentanil when CARDEAN was Ͼ60. The primary outcome was the number of observed movements. RESULTS: Data were analyzed in 146 patients (control: 75; CARDEAN: 71). The doses of propofol and alfentanil were similar in both groups. When BIS was Ͻ60, movements were less frequent in the CARDEAN group (3.3 movements/100 min [2.3-4.8]) than in the control group (6.7 [5.3-8.5]) (odds ratio: 0.5 [0.32; 0.76], P ϭ 0.001). During the first 10 minutes of the procedure, the incidence of movements was 38% and 59% in the CARDEAN and control groups, respectively (P ϭ 0.04). CONCLUSION: With BIS Ͻ60, CARDEAN-guided opioid administration is associated with a reduction of 51% of clinically unpredictable movements in unparalyzed patients undergoing colonoscopy. More studies are required to refine the role of CARDEAN in surgical settings.
I
n guiding drug dosing to provide optimal anesthetic conditions, intraoperative recall appears reduced when bispectral index (BIS) is used. [1] [2] [3] Neuromuscular blockade is adequately monitored using a neuromuscular twitch monitor and the train-of-four technique. By contrast, currently available cerebral function monitors have not demonstrated an ability to successfully monitor the third component of anesthesia, intraoperative nociception. 4 Conventional sympathetically mediated signs (i.e., hypertension measured every few minutes and tachycardia assessed continuously) as a measure of intraoperative nociception have not been shown to be an adequate monitor for the titration of opioid analgesics for the prevention of movement on a second-by-second basis. This lack of a monitor to determine adequate therapeutic intervention for the management of intraoperative nociception potentially increases the use of neuromuscular blockade to avoid movement linked to intraoperative nociception or may result in the overdosing of opioid analgesics.
A cardiovascular depth of anesthesia index, CARDEAN (Alpha-2, Lyon, France), is an algorithm based on beatby-beat arterial blood pressure (BP) changes followed by tachycardia, which estimates online the intraoperative nociception. CARDEAN 1.0 was written through the retrospective analysis of a database including 40 unparalyzed patients undergoing orthopedic surgery to achieve 100% sensitivity for movement prediction. 5 The present prospective randomized controlled clinical trial was designed to assess the possibility of predicting online movement during surgery using this prototype software, CARDEAN 2.0 (Appendix, see Supplemental Digital Content 1, http://links.lww.com/AA/A73). 6 After performing a pilot study to confirm its potential utility, 7 we designed a larger study with patients undergoing colonoscopy, alone or combined with gastroscopy. Because movements are not a concern for the endoscopist in this setting and because it would be important to establish the utility of this index where movement is not critical to the outcome, we chose these procedures for our initial large-scale utility trial. Thus, the main outcome measure was not the clinical usefulness per se but testing the software under real-life conditions. The primary end point was the possible reduction of movement in the CARDEAN group after the administration of alfentanil when CARDEAN crossed a threshold.
METHODS Patients
After receiving approval from our IRB and written informed consent, 159 ASA physical status I or II patients (aged 20 -75 years), presenting for endoscopy (colonoscopy Ϯ gastroscopy) in a strictly supine position, under general anesthesia, were enrolled. No patient had any history of cardiovascular (including nonsinus rhythm), endocrinologic, neurologic, and autonomic diseases or was taking any drug for the treatment or management of such pathologies. No patient included in previous studies 5, 7 was included. Patients were monitored with an electrocardiogram, oscillometric BP, pulse oximeter (Spo 2 ), and capnograph (end-tidal CO 2 through an anesthesia mask; Siemens SC 7000, Erlangen, Germany). Respiratory rate (Biopac RSP 100B, Goleta, CA), BIS (XP4.0, Aspect, Newton, MA; refreshment of display set at 30 seconds), noninvasive beatby-beat BP 8 (Finapres 2300, Ohmeda, Madison, WI), and CARDEAN 2.0 5 were recorded for all patients. The Finapres was levelled to the heart on one arm, which was warmed throughout surgery using an air warmer device (Bair Hugger, Arizant Healthcare, Eden Prairie, MN) and a blanket.
Anesthesia
Patients were not premedicated. Induction of anesthesia was performed with propofol (initial effect-site concentration ϭ 4 g ⅐ mL Ϫ1 ; Master TCI Diprifusor-Zeneca, Fresenius-Kabi, Bad Homburg, Germany). 9 Later, the effect-site concentration was adjusted to achieve 40 Ͻ BIS Ͻ 60 and stable circulatory variables (systolic BP [SBP] assessed on oscillometric BP measured every 5 minutes and continuous heart rate [HR] observed on the monitor to be maintained both within Ϯ20% of perioperative values). Patients were allowed to breathe spontaneously. Spo 2 Ͼ95% was maintained with oxygen supplementation and/or jaw lift, insertion of an airway cannula, or positive pressure ventilation of the lungs via a facemask, as needed. Endotracheal intubation was not performed, and when clinically indicated, patients were excluded from the study. The end of induction was defined as the combination of BIS Ͻ60 and immobility lasting Ͼ1 minute after forceful jaw lift by the same 2 anesthesiologists (PFW and CL). After induction, if propofol alone was not sufficient to reach immobility after jaw lift, an alfentanil bolus (3.5 g ⅐ kg Ϫ1 ) was administered. The study duration was defined as the interval between the beginning of the procedure (gastroscopy: introduction of the probe into the mouth after completion of induction according to set criteria; colonoscopy: lubrication of the anal margin) and the beginning of the withdrawal of the colonoscope from the right colon. To accelerate emergence, propofol infusion was discontinued immediately after the beginning of the withdrawal of the colonoscope. Patients were randomized to 2 groups: 1. Control: (i) Propofol was titrated to achieve a 40 Ͻ BIS Ͻ 60. Given the brevity of the procedure, sometimes BIS reached values between 25 and 40 or Ͼ60. When hypotension or bradycardia occurred (20% decrease below presurgical baseline), the propofol concentration was reduced as long as BIS was maintained (40 Ͻ BIS Ͻ 60). When tachycardia or hypertension (20% above presurgical baseline) occurred, the propofol concentration was increased, maintaining BIS Ͼ40 and Ͻ60.
(ii) When the propofol increase failed, after 5 minutes, to maintain HR and SBP within 20% of the baseline value, alfentanil (3.5 g ⅐ kg Ϫ1 ) was administered. If any movement occurred, alfentanil (3.5 g ⅐ kg Ϫ1 ) was also administered. Additional boluses of alfentanil were administered if movement persisted after 1 minute. When repeated movements occurred, a movement was considered distinct from the previous movement when it occurred at least 1 minute after the end of the previous movement. Alfentanil was administered only if ventilation was deemed adequate (respiratory rate Ն5 breaths/min, Spo 2 Ͼ95%). The procedure was not stopped if a movement occurred. When ventilation was inadequate, while BIS Ͻ60, movement was tolerated without any increase in propofol concentration or alfentanil administration. 2. CARDEAN: (i) Propofol was administered as in the control group. (ii) Alfentanil 3.5 g ⅐ kg Ϫ1 was administered if conventional signs occurred as in the control group or if an observer (AC) warned the anesthesiologist that the CARDEAN index crossed a predefined threshold (Ն60). The anesthesiologist, the gastroenterologist, and his nurse were all blinded to both the Finapres and the CARDEAN readings throughout the study. Only the observer not involved in anesthesia administration or in the procedure had access to the CARDEAN and Finapres data. Thus, the anesthesiologist was double blinded to group assignment up to the study end in the control group and until the first notified CARDEAN Ն60 in the CARDEAN group, and the gastroenterologist and his nurse were double blinded from assignment up to the end of study in both groups. First, the observer discreetly touched the shoulder of the anesthesiologist when CARDEAN crossed the threshold. Second, the room was darkened as is common in the endoscopy setting. Third, the gastroenterology team concentrated on the video screen to perform the procedure. A movement was defined as a head, limb, or finger movement, grimacing, or a groan. Swallowing, cough, hiccup, and yawn were not considered movements. The gastroenterologist, his nurse, the anesthesiologist, and the observer were all instructed to look for the patient's movements from the start of endoscopy until 2 minutes after propofol discontinuation. When any of these 4 individuals observed any movement, the anesthesiologist was warned. The anesthesiologist made the final determination whether or not this was an actual movement. All movements were immediately collected on a data sheet by the observer. The total number of movements was verified and recorded by the anesthesiologist immediately after the end of procedure. Adverse events were defined as follows: (i) tachycardia: HR Ͼ90 bpm; (ii) bradycardia: HR Ͻ40 bpm; (iii) hypertension: SBP Ͼ140 mm Hg measured by oscillometric method; (iv) hypotension: SBP Ͻ90 mm Hg; (v) hypoventilation: respiratory rate Ͻ5 breaths/min with the jaw lifted; (vi) apnea: no observed breathing for Ͼ20 seconds even if the jaw was lifted; and (vii) desaturation: Spo 2 Ͻ95%.
Data Analysis
The maximal BIS value was calculated on 1-minute analysis periods. In the absence of movements or alfentanil boluses, the 1-minute periods started 2 minutes before the start of endoscopy and were adjacent to each other until not Ͼ2 minutes after propofol discontinuation. If an event such as movement or alfentanil bolus occurred, the 1-minute periods were all adjacent and occurred before each event and after the last event. Three types of movements were excluded from analysis ( Fig. 1 ): (i) when cardiovascular and/or BIS signals were interrupted or of poor quality 2 minutes before a movement; (ii) when a movement occurred spontaneously before the start of endoscopy compatible with incomplete induction; or (iii) when the administration of an alfentanil bolus was not performed before the movement despite CARDEAN warning because of apnea, slow respiratory rate, or desaturation. The remaining movements were counted separately as a function of BIS: (i) movements with BIS Ն60 Ͻ1 minute before movement could be linked to cortical arousal, not to nociception. The normalized incidence of these movements per time unit was calculated for each patient by dividing the number of these movements by the total number of 1-minute periods with BIS Ն60; (ii) movements with BIS Ͻ60 Ͼ1 minute before the movement was considered a withdrawal movement linked to nociception. The normalized incidence of these movements per time unit was calculated for each patient by dividing the number of these movements by the total period when BIS Ͻ60; (iii) among movements preceded by BIS Ͻ60 for Ͼ1 minute, 2 categories of movements were distinguished: movements followed by an increase of the BIS Ն60 within 1 minute and movements followed by the BIS Ͻ60 within 1 minute; and (iv) the beginning of colonoscopy was considered a standardized stimulus: among movements preceded by BIS Ͻ60 for Ͼ1 minute, the normalized incidence of movements occurring within 10 minutes after the beginning of the colonoscopy was also calculated.
Receiver Operating Characteristic Analysis
Because CARDEAN patients were injected with alfentanil, after following observation of CARDEAN Ն60, the ability of CARDEAN to predict movement could not be tested using a receiver operating characteristic (ROC) in CARDEAN patients. Thus, ROC analysis was restricted to the control group. Given the large number of events and/or cortical arousals (BIS Ն60) over a short procedure, the following periods were excluded from analysis: (i) periods Յ5 minutes if any event (induction of anesthesia, movement, cough, etc.) occurred before a cough, and all the adjacent 1-minute periods during the cough; (ii) periods Յ5 minutes if any event occurred before a movement preceded by BIS Ն60 and all the adjacent 1-minute periods during this movement; (iii) periods Յ5 minutes if any event occurred before a propofol bolus or an increase by Ͼ10% of the propofol concentration imposed by an increase of the BIS Ն60, 1 minute during and 1 minute after the propofol bolus, or concentration increase. In the remaining periods, the maximum of the CARDEAN index was computed on 5-minute periods or at least 2-minute periods if any event occurred before a movement, and on 2-minute periods when no movement was observed. All the periods lasting Ͻ2 minutes were discarded. A positive event was considered the occurrence of movement. A negative event was considered the absence of movement. The delay between the CARDEAN Ն60 and the movement was measured in the control group for the 12 movements without any interfering event (induction of anesthesia, movement, cough, etc.) 5 minutes before the movement. Apneas after administration of propofol alone were counted separately from apneas immediately after alfentanil. The doses of propofol and alfentanil (only for those patients having received alfentanil) were normalized to the study duration and patient's weight.
Sample Size
The number of patients needed was calculated according to the result of a pilot study 7 (n ϭ 22 patients) showing a reduction of 65% of the incidence rate of movements in the CARDEAN group. Control group: incidence rate (normalized to duration of procedure; Poisson model; 95% confidence interval [CI]; number/100 min; raw data) 5.4 movements per 100 patient ϫ minutes; CARDEAN group: 1.9 movements per 100 patient ϫ minutes. For an ␣ risk of 5% and a statistical power of 90%, 73 patients were to be included in each group. Secondary end points (propofol or alfentanil dose, brady/tachycardia, hypo/hypertension, apnea/hypoventilation, and duration to emergence) were not considered. The alfentanil dose was optimized to 3.5 g ⅐ kg Ϫ1 to suppress movement with minimal respiratory and circulatory side effects.
Statistical Analysis
Patients at inclusion were compared between groups using the Student t test or a Mann-Whitney nonparametric test when the distribution was Gaussian or non-Gaussian, respectively (Stata 10.0, StataCorp LP, College Station, TX).
Skewness was determined by observation of raw data. 10 2 test was used for categorical characteristics. The number of movements occurring during the procedure (total number, movements after exclusions, movements preceded by BIS Ն60, movements preceded by BIS Ͻ60, movements preceded by BIS Ͻ60 and occurring within 10 minutes after beginning of colonoscopy [standardized stimulus]) was compared between groups using a Poisson regression, considering the duration of the procedure for each patient. The odds ratio with its 95% CI was used to quantify the CARDEAN effect on the risk of occurrence of movement. Side effects were analyzed as binary variables (at least 1 event versus no event) and compared between groups using a logistic regression adjusted on duration of the study period. ROC analysis was performed using SPSS 17.0 (SPSS, Chicago, IL). The area under the ROC curve and its 95% CI were computed to quantify the ability of CARDEAN to predict movement. Data are expressed as mean Ϯ sd or median (range) where appropriate. P Ͻ0.05 was considered significant.
RESULTS
Thirteen patients were excluded for the following reasons: broncho-or laryngospasm or severe desaturation leading to endotracheal intubation (2 patients); severe desaturation in a tracheotomized patient (1 patient); intestinal perforation and endotracheal intubation (1 patient); poor cardiovascular signals (2 patients); dose of alfentanil not in agreement with preset dose (2 patients); and technical difficulties with the online display of the CARDEAN 2.0 version led us to exclude 5 patients in the CARDEAN group, which had erroneously received alfentanil without Blood Pressure, Heart Rate, and Depth of Anesthesia CARDEAN Ն60. Thus, 146 patients underwent final analysis (control: n ϭ 75; CARDEAN: n ϭ 71; Fig. 1 ). No differences were observed with respect to age, weight, body mass index, gender, colonoscopy alone versus gastroscopy combined with colonoscopy, duration of endoscopy, normalized doses of propofol or alfentanil, hypoventilation, hypoxia, hypo/hypertension, brady/tachycardia, and duration of emergence (Tables 1 and 2 ). In most patients, a 25 Ͻ BIS Ͻ 40 was observed at some intervals (duration not significant [NS] between groups).
Movements
The number of movements was lower in the CARDEAN group (details for raw data; data after excluded movements; BIS Ͻ60 before movement; and movement after standardized stimulus; Table 3 and Fig. 2A ). When only data in which BIS Ͻ60 before movement (i.e., adequate hypnosis) were considered, a 51% reduction was observed in the CARDEAN group (P ϭ 0.001; Fig. 2A and Table 3 ). When the 10 minutes after the beginning of colonoscopy are considered as a standardized stimulus, a 40% reduction in movements was observed (P ϭ 0.04; Table 3 ). In the control group, CARDEAN threshold (Ͼ60) was crossed 96 Ϯ 77 seconds (range: 12-297 seconds, n ϭ 12 movements) before the movement actually occurred. For CARDEAN ϭ 60, a ROC curve (Fig. 2D) for the control group showed a sensitivity ϭ 30% (19%-43%), specificity ϭ 86% (82%-90%), positive predictive value ϭ 26% (17%-37%), and negative predictive value ϭ 88% (83%-91%). The area under the ROC curve was 0.68 (0.61-0.75) (P Ͻ 0.001).
Opioid Analgesics
During induction, 14 patients received alfentanil (NS between groups). The normalized doses for propofol and alfentanil were not different. During the procedure, the number of patients having received at least 1 bolus of alfentanil was significantly higher in the CARDEAN group (control: 61.3%; CARDEAN: 83.1%, P ϭ 0.003; Table 2 ). In the CARDEAN group, only 3 movements occurred within 5 minutes after CARDEAN-guided alfentanil administration as opposed to 14 movements occurring in the control group (CARDEAN: 62 boluses, recurrence rate ϭ 3 of 62 ϭ 4.8%; control: 78 boluses, recurrence rate ϭ 14 of 78 ϭ 17.9%; P ϭ 0.015).
DISCUSSION
We tested the utility of the CARDEAN index to guide alfentanil administration to prevent movement during colonoscopy/gastroscopy when BIS was maintained between 40 and 60 using target-controlled infusion propofol. The use of the CARDEAN index reduced the number of movements by 51% during endoscopy (Table 3 ; Fig. 2 , A and D). This confirms previous retrospective 5 and pilot prospective 7 studies. In the CARDEAN group, more patients presented no movement at all, and fewer patients presented many movements (Fig. 2, B and C) . Movements occurring with a BIS Ն60 are differentiated from movements occurring with a BIS Ͻ60. Thus, CARDEAN in combination with the BIS may be able to differentiate between inadequate intraoperative antinociception and cortical arousal. The CARDEAN threshold was crossed at intervals allowing sufficient time for an effective intervention to abort movement (present data: 12-297 seconds; previous data: 15-274 seconds 5 ). More patients received alfentanil in the CARDEAN group. However, the normalized dose of alfentanil administered did not reach significance between groups; the difference does not lie in the total amount of opioid analgesics administered but rather in its administration only when and if needed before movement. The recurrence of movement was 5% in the CARDEAN group versus 18% in the control group. Thus, preemptive administration of opioid analgesics seems superior to administration after movement. Although the normalized dose of alfentanil administered did not reach significance between groups, a trend to a higher incidence of apnea was observed in the CARDEAN group (P ϭ 0.06, Table 2 ), a result of reducing the incidence of movement when patients' lungs are not ventilated. However, the aim of this study was not to increase immobility per se in the endoscopy setting but rather to refine CARDEAN for further application in the setting of patients under mechanical ventilation presenting for operations with more intense noxious stimuli.
Does absence of movement imply analgesia? Minimal alveolar concentration was defined on the basis of the absence of a withdrawal movement upon a standardized stimulus in unparalyzed animals. 11 Thus, absence of movement should be restricted to infer absence of intraoperative nociception. By contrast, proper analgesia requires addressing the subjective experience of an awake patient. When BIS was Ͻ60, the reduction in movement suggests that these movements were not attributable to cortical arousal but to nociception. If the analysis excludes movements preceded by BIS Ͻ60 and followed by BIS Ͼ60, the reduction of movement observed in the CARDEAN group was still observed (Table 3) . Besides, these movements followed by BIS Ն60 are not necessarily linked to a late detection of a cortical arousal: the electromyogram may affect BIS. 12 
Limitations
In the CARDEAN group, the anesthesiologist was double blinded only up to the first CARDEAN-guided injection of alfentanil. Further administration of alfentanil was guided both by CARDEAN and movement. By contrast, the gastroenterologist remained totally blinded throughout the study in both groups. The only possible biases in the CARDEAN group were (i) underestimation of the number of movements (however, the gastroenterologist was totally double-blinded), and (ii) increase in the propofol doses in the CARDEAN group (however, the doses were similar). A truly double-blind prospective trial will be possible only when CARDEAN will automatically guide the administration of the opioid analgesics. Other trials dealing with BIS . B and C, Movements preceded by a BIS Ͻ60 at least 1 minute before the movement for each patient throughout study (B) and within 10 minutes after beginning of colonoscopy considered a standardized stimulus (C). D, Receiver operating characteristic curve for the prediction of movement by CARDEAN in the control group. The cross indicates the sensitivity (y axis) and specificity (x axis) for CARDEAN ϭ 60. were not truly double-blind. [1] [2] [3] 13 This did not invalidate their results. Given the technological limitations, the design is reasonably valid. Hypnosis was set to 40 Ͻ BIS Ͻ 60. Given the highly unstable procedure, 25 Ͻ BIS Ͻ 40 was observed (NS between groups). Further trials should use automated procedures 14 to drive propofol administration within set BIS limits during longer procedures. A pilot study 7 allowed the calculation of a sample to show only a reduction in intraoperative movement. Thus, no inference can be drawn beyond movement. We only looked for intraoperative movements under real-life conditions. Thus, further studies should evaluate the performance of CARDEAN during a standardized stimuli, as in a minimal alveolar concentration study. 11 However, if the beginning of colonoscopy is considered a standardized stimulus similar to incision, movements under real-life conditions and standardized stimuli were reduced by CARDEAN (51% and 40%, respectively). To assess the clinical usefulness of CARDEAN will require more intense stimuli, e.g., during orthopedic or intraabdominal surgery. CARDEAN needs refinement because it offers no value between consecutive pillars (Fig. 3) . Another unsolved problem is that after an increase of CARDEAN Ն60, a value Ͻ60 could be observed (see immediately before movement M2 in Fig. 3 ). If this value Ͻ60 is within 5 minutes after a CARDEAN Ն60, this value Ͻ60 does not invalidate the predictive power for movement of the CARDEAN value Ն60. Movements could be preceded by sympathetic bursts, leading to CARDEAN Ն60. However, after a sympathetic surge that indicates nociception and generates CARDEAN Ն60, sympathetic nervous activity may recede leading to CARDEAN Ͻ60 just before movement. Our subset of patients was highly homogeneous, in sinus rhythm, and without hypovolemia, hypothermia, or any elderly/coronary patient or patient treated with ␤-blockers or ␣-2 agonists. Obviously, CARDEAN needs further validation. CARDEAN works only in operating rooms equipped with a continuous noninvasive or invasive beat-by-beat BP monitor; the algorithm should be adapted to use existing sensors in the operating room. Finally, sensitivity needs to be much improved to allow for daily clinical use.
CARDEAN scrutinizes the small changes in SBP and HR occurring before hypertension and tachycardia conventionally observed by the clinician. The pressure increase followed by a bradycardia (baroreflex coupling) is transformed, by the somato-sympathetic reflex, into hypertension followed by tachycardia observed on line on a beat-by-beat basis. 15 CARDEAN is based anatomically and functionally on the projection of the pain pathways on the core circuitry of the sympathetic cardiac and vasomotor baroreflex. 16, 17 Will CARDEAN detect 100% of intraoperative nociception? No, the hypertension-tachycardia underlying CARDEAN occurs only before 80% to 85% of observed movements (Cividjian, unpublished data). Will CARDEAN alone offer total monitoring of movement and intraoperative antinociception? No, movements M1 and M2 were predicted by CARDEAN Ն60 increases but not by BIS Ն60 (Fig. 3) . Conventional signs do not allow assessment of depth of anesthesia as early as CARDEAN. By contrast, M3 was predicted by BIS Ն60 (i.e., cortical arousal) but not by CARDEAN Ն60. Thus, both BIS and CARDEAN need to be used in conjunction to predict movement.
In conclusion, when alfentanil administration was guided by an online beat-by-beat cardiovascular index, CARDEAN, in a prospective randomized manner during colonoscopy/gastroscopy, a 51% reduction of movements was observed in patients (n ϭ 146) receiving similar doses of propofol and alfentanil. These data are encouraging and suggest improvement in the sensitivity of CARDEAN and its validation to guide opiate administration in patients receiving mechanical ventilation under a standardized surgical stimulus and operations with more intense noxious stimuli. R-R interval, noninvasive beat-by-beat systolic blood pressure (SBP), CARDEAN and BIS (threshold ϭ 60), and propofol effect-site concentration (Propofol Ce). C ϭ cough; M1 to M4 ϭ unexpected movements, EO ϭ eyes opening to command. M3 was not followed by an alfentanil bolus; alfentanil had been administered approximately 1 minute before M3. M1 and M2 were preceded by BIS Ͻ60 during the 1-minute period before the movement, which stopped after the alfentanil bolus. M1 and M2 were associated with CARDEAN Ͼ60 (presumed intraoperative nociception). M3 was preceded by BIS Ն60 (presumed cortical arousal) during the 1-minute period before M3 and occurred despite an alfentanil bolus approximately 1 minute before. Neither increased SBP nor heart rate was apparent before M1 and M2. Increased BIS variability was not apparent before M2. CARDEAN may predict movements not predicted by BIS or by conventional signs. M4 occurred after the end of study and was not included in the analysis. 
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